Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 36, 2022 - Issue 10
413
Views
2
CrossRef citations to date
0
Altmetric
Short Communications

The role of active metabolites isolated from Jasminum multiflorum flowers against hepatitis C virus infection and related hepatocellular carcinoma

, , , , , , & show all
Pages 2625-2629 | Received 17 Feb 2021, Accepted 31 Mar 2021, Published online: 07 May 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ahmed A. Al-Karmalawy, Radwan Alnajjar, Ayman Abo Elmaaty, Faizah A. Binjubair, Sara T. Al-Rashood, Basma S. Mansour, Ahmed Elkamhawy, Wagdy M. Eldehna & Khaled Ahmed Mansour. (2023) Investigating the promising SARS-CoV-2 main protease inhibitory activity of secoiridoids isolated from Jasminum humile; in silico and in virto assessments with structure-activity relationship. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-13.
Read now

Articles from other publishers (1)

Moneerah J. Alqahtani, Sally A. Mostafa, Ismail A. Hussein, Seham Elhawary, Fatma A. Mokhtar, Sarah Albogami, Michał Tomczyk, Gaber El-Saber Batiha & Walaa A. Negm. (2022) Metabolic Profiling of Jasminum grandiflorum L. Flowers and Protective Role against Cisplatin-Induced Nephrotoxicity: Network Pharmacology and In Vivo Validation. Metabolites 12:9, pages 792.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.